Correction : Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer
| Errataetall: |
ErratumFor: Oncotarget. 2017 Jul 15;8(41):69779-69796. - PMID 29050241 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Oncotarget - 15(2024) vom: 22. Feb., Seite 142 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zanjirband, Maryam [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 26.02.2024 Date Revised 26.02.2024 published: Electronic ErratumFor: Oncotarget. 2017 Jul 15;8(41):69779-69796. - PMID 29050241 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.18632/oncotarget.28523 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368768074 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368768074 | ||
| 003 | DE-627 | ||
| 005 | 20240229155408.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18632/oncotarget.28523 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1306.xml |
| 035 | |a (DE-627)NLM368768074 | ||
| 035 | |a (NLM)38386812 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zanjirband, Maryam |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction |b Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.02.2024 | ||
| 500 | |a Date Revised 26.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ErratumFor: Oncotarget. 2017 Jul 15;8(41):69779-69796. - PMID 29050241 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Curtin, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Edmondson, Richard J |e verfasserin |4 aut | |
| 700 | 1 | |a Lunec, John |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncotarget |d 2010 |g 15(2024) vom: 22. Feb., Seite 142 |w (DE-627)NLM199620113 |x 1949-2553 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2024 |g day:22 |g month:02 |g pages:142 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18632/oncotarget.28523 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2024 |b 22 |c 02 |h 142 | ||